Transient portal vein thrombosis in liver cirrhosis

BMC Med. 2018 Jun 5;16(1):83. doi: 10.1186/s12916-018-1069-8.

Abstract

In real-world clinical practice, the acceptance of anticoagulation therapy in the management of portal vein thrombosis (PVT) in patients with cirrhosis is limited by the fear of an increased bleeding risk. Additionally, accumulating evidence indicates that spontaneous recanalization of PVT may occur in the absence of antithrombotic treatment. Therefore, risk stratification based on outcomes in such patients is crucial for determining a therapeutic strategy. In this paper, we draw attention to the distinct clinical entity, "transient PVT" by introducing two cases with PVT that spontaneously recanalized in the absence of antithrombotic treatment. We reviewed the available data regarding the probability of and predictors for spontaneous recanalization of PVT. Available data suggest singling out transient thrombosis in the natural history of PVT in patients with cirrhosis because of its prognostic and management implications.

Keywords: Anticoagulation; Liver cirrhosis; Portal vein thrombosis; Recanalization; Transient.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Adult
  • Anticoagulants / pharmacology
  • Anticoagulants / therapeutic use*
  • Female
  • Humans
  • Liver Cirrhosis / complications*
  • Liver Cirrhosis / pathology
  • Male
  • Portal Vein / abnormalities*
  • Prognosis
  • Treatment Outcome
  • Venous Thrombosis / etiology*
  • Venous Thrombosis / mortality
  • Venous Thrombosis / pathology

Substances

  • Anticoagulants